Liver Tumors

Pediatric Surgery: Sixth Edition

Volumn 1-2, Issue , 2006, Pages 502-514

  Atkinson, James B ^a   DeUgarte, Daniel A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84918865175     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-02842-4.50033-4     Document Type: Chapter

References (79)

1. Achilleos OA, Buist LJ, Kelly DA, et al. Unresectable hepatic tumors in childhood and the role of liver transplantation. J Pediatr Surg 1996, 31:1563-1567.
2. Ahrar K, Gupta S Hepatic artery embolization for hepatocellular carcinoma: Technique, patient selection, and outcomes. Surg Oncol Clin N Am 2003, 12:105-126.
3. Al-Qabandi W, Jenkinson H, Buckels JA, et al. Orthotopic liver transplantation for unresectable hepatoblastoma: A single center's experience. J Pediatr Surg 1999, 34:1261-1264.
4. Arcement CM, Towbin RB, Meza MP, et al. Intrahepa-tic chemoembolization in unresectable pediatric liver malignancies. Pediatr Radiol 2000, 30:779-785.
5. Boechat MI, Kangarloo H, Ortega J, et al. Primary liver tumors in children: Comparison of CT and MR imaging. Radiology 1988, 169:727-732.
6. Buendia MA Genetic alterations in hepatoblastoma and hepatocellular carcinoma: Common and distinctive aspects. Med Pediatr Oncol 2002, 39:530-535.
7. Cao G, Kuiryama S, Gao J, et al. Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter. Eur J Cancer 2001, 37:140-147.
8. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepato-cellular carcinoma in children. N Engl J Med 1997, 336:1855-1859.
9. Chardot C, Saint-Martin C, Gilles A, et al. Living related liver transplantation and vena cava reconstruction after total hepatectomy including vena cava for hepatoblastoma. Transplantation 2002, 73:90-92.
10. Chen JC, Chen CC, Chen WJ, et al. Hepatocellular carcinoma in children: Clinical review and comparison with adult cases. J Pediatr Surg 1998, 33:1350-1354.
11. Clericuzio CL, Chen E, McNeil DE, et al. Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolate hemihyperplasia. J Pediatr 2003, 143:270-272.
12. Craig JR, Peters RL, Edmondson HA, et al. Fibrolamellar carcinoma of the liver; a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980, 46:372-379.
13. Czauderna P, Mackinlay G, Perilongo G, et al. Hepatocellular carcinoma in children: Results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol 2002, 20:2798-2804.
14. Darbari A, Sabin KM, Shapiro CN, et al. Epidemiology of primary hepatic malignancies in US children. Hepatology 2003, 38:560-566.
15. de Campo M, de Campo JF Ultrasound of primary hepatic tumours in children. Pediatr Radiol 1988, 19:19-24.
16. Evans AE, Land VJ, Newton WA, et al. Combination chemotherapy (vincristine, Adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer 1982, 50:821-826.
17. Exelby PR, Filler RM, Grosfeld JL Liver tumors in children with particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey 1974. J Pediatr Surg 1975, 10:329-337.
18. Feusner J, Plaschkes J Hepatoblastoma and low birth weight: A trend or chance observation?. Med Pediatr Oncol 2002, 39:508-509.
19. Finegold MJ Chemotherapy for suspected hepatoblastoma without efforts at surgical resection is a bad practice. Med Pediatr Oncol 2002, 39:484-486.
20. Fuchs J, Rydzynski J, Hecker H, et al. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma a report from the German Cooperative Liver Tumour Studies HB 89 and 94. Eur J Pediatr Surg 2002, 12:255-261.
21. Fuchs J, Rydzynski J, Von Schweinitz D, et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: A report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 2002, 95:172-182.
22. Haas JE, Feusner JH, Finegold MJ Small cell undifferentiated histology in hepatoblastoma may be unfavorable. Cancer 2001, 92:3130-3134.
23. Helmberger TK, Ros PR, Mergo PJ, et al. Pediatric liver neoplasms: A radiologic-pathologic correlation. Eur Radiol 1999, 9:1339-1347.
24. Hemming AW, Reed AI, Langhan MR, et al. Hepatic vein reconstruction for resection of hepatic tumors. Am Surg 2002, 235:850-858.
25. Hughes LJ, Michels VV Risk of hepatoblastoma in familial adenomatous polyposis. Am J Med Genet 1992, 43:1023-1025.
26. Ikeda H, Hachitanda Y, Tanimura M, et al. Development of unfavorable hepatoblastoma in children of very low birth weight: Results of a surgical and pathologic review. Cancer 1998, 82:1789-1796.
27. Kanai F Transcriptional targeted gene therapy for hepatocellular carcinoma by adenovirus vector. Mol Biotechnol 2001, 18:243-250.
28. Kanai F, Lan KH, Shiratori Y, et al. In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene. Cancer Res 1997, 47:561-565.
29. Katzenstein HM, Krailo MD, Malogolowkin MH, et al. Hepatocellular carcinoma in children and adolescents: Results from the Pediatric Oncology Group and the Children's Cancer Group Intergroup Study. J Clin Oncol 2002, 20:2789-2797.
30. Katzenstein HM, Krailo MD, Malogolowkin MH, et al. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 2003, 97:2006-2012.
31. Katzenstein HM, Rigsby C, Shaw PH, et al. Novel therapeutic approaches in the treatment of children with hepatoblastoma. J Pediatr Hematol Oncol 2002, 24:751-755.
32. Koneru B, Flye MW, Bussutil RW, et al. Liver transplantation for hepatoblastoma: The American experience. Ann Surg 1991, 213:118-121.
33. Lack EE, Neave C, Vawter GF Hepatocellular carcinoma: Review of 32 cases in childhood and adolescence. Cancer 1983, 52:1510-1515.
34. LaQuaglia MP, Shorter NA, Blumgart LH Central hepatic resection for pediatric tumors. J Pediatr Surg 2002, 37:986-989.
35. Lau WY, Leung TW, Yu SC, et al. Percutaneous local ablative therapy for hepatocellular carcinoma: A review and look into the future. Ann Surg 2003, 237:171-179.
36. Lee CL, Ko YC Hepatitis B vaccination and hepatocellular carcinoma in Taiwan. Pediatrics 1997, 99:351-353.
37. Liu DC, Vogel AM, Gulec S, et al. Hepatectomy in children under total hepatic occlusion. Am Surg 2003, 69:539-541.
38. Llovet JM, Bru C, Bruix J Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999, 19:329-338.
39. Llovet JM, Burroughs A, Bruix J Hepatocellular carcinoma. Lancet 2003, 362:1907-1917.
40. Malogolowkin MH, Stanley P, Steele DA, et al. Feasibility and toxicity of chemoembolization for children with liver tumors. J Clin Oncol 2000, 18:1279-1284.
41. Martinez JA, Rigamonti W, Rahier J, et al. Preserved vascu-lar homograft for revascularization of pediatric liver transplant: A clinical, histological, and bacteriological study. Transplantation 1999, 68:672-677.
42. McCrudden KW, Hopkins B, Frischer J, et al. Anti-VEGF antibody in experimental hepatoblastoma: Suppression of tumor growth and altered angiogenesis. J Pediatr Surg 2003, 38:308-314.
43. McCrudden KW, Yokoi A, Thosani A, et al. Topotecan is anti-angiogenic in experimental hepatoblastoma. J Pediatr Surg 2002, 37:857-861.
44. Molmenti EP, Wilkinson K, Molmenti H, et al. Treatment of unresectable hepatoblastoma with liver transplantation in the pediatric population. Am J Transplant 2002, 2:535-538.
45. Morino M, Morra I, Rosso E, et al. Laparoscopic vs open hepatic resection: A comparative study. Surg Endosc 2003, 17:1914-1918.
46. Ni Y-H, Change M-H, Huang L-M, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001, 135:796.
47. Ohashi M, Kanai F, Tateishi K, et al. Target gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus. Biochem Biophys Res Commun 2001, 282:529-535.
48. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients. Cancer 1985, 56:918-928.
49. Ortega JA, Douglass EC, Feusner JH, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 2000, 18:2665-2675.
50. Ortega JA, Krailo MD, Hans JE, et al. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: A report from the Children's Cancer Study Group. J Clin Oncol 1991, 9:2167.
51. Otte JB, Aronson DC, Brown J, et al. Liver transplanta-tion for hepatoblastoma: Results from the International Society of Pediatric Oncology (SlOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 2004, 42:74-83.
52. Otte JB, Aronson D, Vraux H, et al. Preoperative chemotherapy, major liver resection, and transplantation for primary malignancies in children. Transplant Proc 2001, 28:2393.
53. Oue T, Fukuzawa M, Kusafuka T, et al. Transcather arterial chemoembolization in the treatment of hepatoblastoma. J Pediatr Surg 1998, 33:1771-1775.
54. Oue T, Kubota A, Okuyama H, et al. Hepatoblastoma in children of extremely low birth weight: A report from a single perinatal center. J Pediatr Surg 2003, 38:134-137.
55. Palmer RD, Williams DM Dramatic response of multiply relapsed hepatoblastoma to irinotecan (CPT-11). Med Pediatr Oncol 2003, 41:78-80.
56. Perilongo G, Brown J, Shafford E, et al. Hepatoblastoma presenting with lung metastases: Treatment results of the first cooperative, prospective study of the International Society of Pediatric Oncology on childhood liver tumors. Cancer 2000, 89:1845-1853.
57. Pritchard J, Brown J, Shafford E, et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: A successful approach results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol 2000, 18:3819-3828.
58. Ramanujam TM, Ramesh JC, Goh DW, et al. Malignant transformation of mesenchymal hamartoma of the liver: Case report and review of the literature. J Pediatr Surg 1999, 34:1684-1686.
59. Ravindra KV, Cullinane C, Lewis IJ, et al. Long-term survival after spontaneous rupture of a malignant rhabdoid tumor of the liver. J Pediatr Surg 2002, 10:1488-1490.
60. Rowland JM Hepatoblastoma: Assessment of criteria for histologic classification. Med Pediatr Oncol 2002, 39:478-483.
61. Ruck P, Xiao JC Stem-like cells in hepatoblastoma. Med Pediatr Oncol 2002, 39:504-507.
62. Sasaki F, Matsunaga T, Iwafuchi M, et al. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor. J Pediatr Surg 2002, 37:851-856.
63. Sato M, Ishida H, Konno K, et al. Liver tumors in children and young patients: Sonographic and color Doppler findings. Abdom Imaging 2000, 25:596-601.
64. Scaife CL, Curley SA Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin N Am 2003, 12:243-255.
65. Schnater JM, Aronson DC, Plaschkes J, et al. Surgical view of the treatment of patients with hepatoblastoma: Results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 2002, 94:1111-1120.
66. Sindhi R, Rosendale J, Mundy D, et al. Impact of segmental grafts on pediatric liver transplantation: A review of the United Network for Organ Sharing Scientific Registry Data (1990-1996). J Pediatr Surg 1999, 34:107-111.
67. Superina RA, Bambini D, Filler RM, et al. A new technique for resecting "unresectable" liver tumors. J Pediatr Surg 2000, 35:1294-1299.
68. Surace C, Leszl A, Perilongo G, et al. Fluorescent in situ hybridization (FISH) reveals frequent and recurrent numerical and structural abnormalities in hepatoblastoma with no informative karyotype. Med Pediatr Oncol 2002, 39:536-539.
69. Szavay PO, Wermes C, Fuchs J, et al. Effective treatment of infantile choriocarcinoma in the liver with chemotherapy and surgical resection: A case report. J Pediatr Surg 2000, 35:1134-1135.
70. Tanimura M, Matsui I, Abe J, et al. Increased risk of hepatoblastoma among immature children with a lower birth weight. Cancer Res 1998, 58:3032-3035.
71. Terracciano LM, Bernasconi B, Ruck P, et al. Comparative genomic hybridization analysis of hepatoblastoma reveals high frequency of X-chromosome gains and similarities between epithelial and stromal components. Hum Pathol 2003, 34:864-871.
72. Tsuchida Y, Ikeda H, Suzuki N, et al. A case of well-differentiated, fetal-type hepatoblastoma with very low serum-alpha-fetoprotein. J Pediatr Surg 1999, 12:1762-1764.
73. von Schweinitz D, Hadam MR, Welte K, et al. Production of interleukin-1β and interleukin-6 in hepatoblastoma. Int J Cancer 1993, 53:728.
74. Webber EM, Morrison KB, Pritchard SL, et al. Undifferentiated embryonal sarcoma of the liver: Results of clinical management in one center. J Pediatr Surg 1999, 34:1641-1644.
75. Weber RG, Pietsch T, von Schweinitz D, et al. Characterization of genomic alterations in hepatoblastomas: A role for gains on chromosomes 8q and 20 as predictors of poor outcome. Am J Pathol 2000, 157:571-578.
76. Weinberg AG, Finegold MJ Primary hepatic tumors of childhood. Hum Pathol 1983, 14:512-537.
77. Yanaga K, Nishizaki T, Yamamoto K, et al. Simplified inflow control using stapling devices for major hepatic resection. Arch Surg 1996, 131:104-106.
78. Zatkova A, Rouillard JM, Hartmann W, et al. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma. Genes Chromosomes Cancer 2004, 39:126-137.
79. Zimmerman A Pediatric liver tumors and hepatic ontogenesis: Common and distinctive pathways. Med Pediatr Oncol 2002, 39:492-503.